Emily Erbelding, M.D., M.P.H., an infectious disease physician with broad research and clinical experience in both government and academic medicine, has been named the new director of the Division of Microbiology and Infectious Diseases at the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health. The division provides funding and other resources for researchers working across the United States and internationally to understand and develop new diagnostics, prevention tools and treatments for established, emerging and re-emerging infectious diseases.
“Emily Erbelding is a highly regarded infectious disease clinician and administrator who will bring a creative and steady hand to managing a particularly challenging research portfolio—one that encompasses a wide range of pathogens,” said NIAID Director Anthony S. Fauci. “The job requires intellectual agility, creativity and a commitment to collaboration across government, academic medicine and industry to ensure that we are well-positioned to address both ongoing and newly emergent disease threats. Emily embodies all these qualities and more, and I am pleased that she has agreed to take on this critical leadership position within NIAID.”
Dr. Erbelding has served as deputy director of the Division of AIDS at NIAID since 2010. She has been involved in all aspects of scientific program management and support, helping to design and implement new initiatives involving basic, translational and clinical research and administering complex extramural grant programs and research infrastructure. Prior to joining NIAID, she spent 14 years on the faculty of the Johns Hopkins University School of Medicine, in the Division of Infectious Diseases. She also served as Director of Clinical Services for the Baltimore City Health Department STD/HIV program.
Dr. Erbelding graduated cum laude from Cornell University, where she also received a Master of Science degree. She earned her medical degree from Indiana University School of Medicine and completed her residency in internal medicine at Northwestern University Medical Center, serving as chief medical resident. While completing a fellowship in infectious diseases at the Johns Hopkins Hospital, she also earned a Master of Public Health degree with a concentration in epidemiology from the Johns Hopkins University School of Public Health. Since 2011, Dr. Erbelding has served as an attending physician for a weekly half-day infectious disease clinic at the Veterans Administration Medical Center in Washington, D.C. She is certified by the American Board of Internal Medicine as a Diplomate of Infectious Disease.
“I am honored to be chosen to lead DMID. The division supports a broad array of vitally important research, and the staff are talented and deeply committed to advancing science and global public health,” said Dr. Erbelding. “I look forward to building productive collaborations across NIAID and with the scientific community and other stakeholders to accelerate scientific progress across the spectrum of infectious diseases.”
Dr. Erbelding replaces Dr. Carole Heilman, Ph.D., who stepped down in early 2016.